This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Barbara Tevelev
Senior Scientist, Molecular Discovery, Cell Line Development, Bioprocess Research and Development at Pfizer

Profile

Barbara Tevelev is a Senior Scientist in the Cell Line Development group at Pfizer’s Biopharma Research and Development Organization. Barbara’s focus is developing and assessing cell lines for monoclonal antibodies and multi-specifics for Phase I projects. She is also responsible for performing phenotypic and genotypic characterization in support of late stage commercial suitability assessment. Some of Barbara’s most recent accomplishments have been centered around developing a new strategy for LIVCA, addressing regulatory concerns, as well as evaluating and streamlining workflows for development and production of complex modalities.

Agenda Sessions

  • Panel Discussion: Cell Line Development: Considerations for the Future

    4:30pm
  • Using Site Specific Integration Expression System to Generate Cell Lines for Multi-specific Modalities

    10:30am